Ipsen S.A. (IPN.PA)

Paris · Healthcare · Drug Manufacturers - Specialty & Generic
€161.60-0.49%As of 2026-11-22 · EUR
Last session low €161.60Last session high €164.30
52-week low €115.6052-week high €174.00
Market cap (USD)
$14.62B
Sector
Healthcare
P/E (TTM)
26.1x
Dividend yield
0.99%

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in EUR.

IndicatorValueReading
RSI (14)58.1In the neutral range (30 to 70)
MACD (12, 26, 9)3.43Below its signal line (3.62); histogram -0.19
Bollinger %B (20, 2)57%Inside the bands (149.29 to 170.88)
SMA 20160.09Price is 0.9% above
SMA 50152.66Price is 5.9% above
SMA 200158.72Price is 1.8% above
ATR (20)2.36% of priceAverage true range per day
52-week position79%In the upper part of the 115.60 to 174.00 range

About Ipsen S.A.

Ipsen S.A., a biopharmaceutical company, develops and commercializes medicines in the areas of oncology, rare disease, and neuroscience in North America, Europe, and internationally.

Latest fiscal yearEnded 2025-12-31: revenue of 3.93B EUR and an operating margin of 24.1%.

More in Drug Manufacturers - Specialty & Generic